Precision Medicine
Showing 51 - 60 of 72 posts
https://www.coltonconsortium.org/projects/biomarker-discovery-for-early-prediction-of-autoimmunity-in-immunotherapy-patients-through-deep-immune-profiling-and-temporal-graph-convolutional-networks/
Using temporal graph machine learning and deep immune profiling to predict which cancer immunotherapy patients will develop autoimmune adverse events before they occur.
https://www.coltonconsortium.org/publications/transcription-factor-etv3-controls-the-tolerogenic-function-of-dendritic-cells/
You might also be interested in… Soluble urine activated leukocyte cell adhesion molecule is a strong predictor of lupus nephritis Rheumatology Chu, D; Schwartz, N; Ampudia, J; Guthridge, J; James, […]
https://www.coltonconsortium.org/publications/transmembrane-domain-driven-pd-1-dimers-mediate-t-cell-inhibition/
https://www.coltonconsortium.org/publications/substantiation-of-trophoblast-transport-of-maternal-anti-ssa-ro-autoantibodies-in-fetuses-with-rapidly-progressive-cardiac-injury-implications-for-neonatal-fc-receptor-blockade/
https://www.coltonconsortium.org/publications/teplizumab-induces-persistent-changes-in-the-antigen-specific-repertoire-in-individuals-at-risk-for-type-1-diabetes/
https://www.coltonconsortium.org/publications/kidney-multiome-based-genetic-scorecard-reveals-convergent-coding-and-regulatory-variants/
https://www.coltonconsortium.org/publications/personalized-treatment-decision-algorithms-for-the-clinical-application-of-serum-neurofilament-light-chain-in-multiple-sclerosis-a-modified-delphi-study/
https://www.coltonconsortium.org/publications/proximity-between-lag-3-and-the-t-cell-receptor-guides-suppression-of-t-cell-activation-and-autoimmunity/
https://www.coltonconsortium.org/publications/psoriatic-arthritis-phenotype-clusters-and-their-association-with-treatment-response-a-real-world-longitudinal-cohort-study-from-the-psoriatic-arthritis-research-consortium/
https://www.coltonconsortium.org/publications/crizanlizumab-for-retinal-vasculopathy-with-cerebral-leukoencephalopathy-in-a-phase-ii-clinical-study/